Freshfields is advising Sanofi S.A. on the deal. Sanofi S.A. announced its pending acquisition of Vigil Neuroscience, Inc., a publicly traded clinical-stage biotechnology company focused on...
You must be a Standard 1 Year member to access this content.
Freshfields Bruckhaus Deringer advised Affimed N.V. (Nasdaq: AFMD) on the deal. Affimed N.V. announced its strategic collaboration with Artiva Biotherapeutics Inc. (‘Artiva‘), likewise an immuno-oncology company, to jointly...
You must be a Standard 1 Year member to access this content.
Freshfields Advised Moderna on the deal. Moderna completed its ten-year agreement with the State of Victoria to establish a state-of-the-art, domestic mRNA vaccine manufacturing facility at...
You must be a Standard 1 Year member to access this content.
